HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrich Hutzschenreuter Selected Research

Ulrich Hutzschenreuter Research Topics

Disease

2Neoplasms (Cancer)
11/2021 - 01/2015
2Breast Neoplasms (Breast Cancer)
11/2021 - 10/2017
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2021
1Lung Neoplasms (Lung Cancer)
01/2019
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
06/2017
1Ovarian Neoplasms (Ovarian Cancer)
12/2015
1Carcinoma (Carcinomatosis)
12/2015
1Colorectal Neoplasms (Colorectal Cancer)
01/2015

Drug/Important Bio-Agent (IBA)

1pegfilgrastim (Neulasta)FDA Link
11/2021
1AnthracyclinesIBA
11/2021
1taxaneIBA
11/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2021
1Sorafenib (BAY 43-9006)FDA Link
06/2017
1Sunitinib (Sutent)FDA Link
06/2017
1Bevacizumab (Avastin)FDA Link
06/2017
1InterferonsIBA
06/2017
1temsirolimusFDA Link
06/2017
1Alkylating AgentsIBA
12/2015
1treosulfanIBA
12/2015
1Irinotecan (Camptosar)FDA LinkGeneric
01/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2015

Therapy/Procedure

1Therapeutics
01/2019
1Aftercare (After-Treatment)
10/2017
1Adjuvant Chemotherapy
10/2017
1Combination Drug Therapy (Combination Chemotherapy)
01/2015
1Drug Therapy (Chemotherapy)
01/2015